Financial & competing interests disclosure
JB Aragon-Ching serves in the Speakers’ Bureau of Bristol Myers Squibb, and has served on the Advisory Board of Exelixis, Pfizer/EMD Serono, Merck and AVEO Pharmaceuticals. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.